The Effects of alpha2-Adrenergic Stimulation with Mivazerol on Myocardial Blood Flow and Function During Coronary Artery Stenosis in Anesthetized Dogs

Abstract
The central sympatholytic effect of (Ye agonists may be beneficial during myocardial ischemia, but could be op- posed by their peripheral vasoconstrictive effect. We studied the effects of mivazerol during periods of mod- erate coronary artery stenosis in anesthetized dogs. Mivazerol decreased heart rate (from 125 + 6 to 106 5 6 bpm) and cardiac output (from 4.4 + 0.6 to 1.8 + 0.2 L/min) under normal conditions, while mean arterial pressure did not change. Mivazerol reduced blood flow in nonischemic myocardium and in the ischemic epi- cardial layer, but blood flow was preserved in the isch- emit midmyocardial and subendocardial layer. Mivaz- erol had no effect on myocardial oxygen extraction during the stenoses, and regional myocardial oxygen consumption was unchanged. However, mivazerol de- creased myocardial oxygen demand from 4.51 + 0.51 to 3.17 -C 0.24 pmol * min-' * g-', thereby reducing oxy- gen deficiency of ischemic myocardium to values sig- nificantly lower than in the placebo group (from 1.07 + 0.32 to 0.47 + 0.41 pm01 * min-' . 8-l). Mivazerol had no effect on myocardial lactate production during the stenoses. We conclude that mivazerol reduced myocar- dial oxygen demand while blood flow was preserved in the inner layers of ischemic myocardium.